August 15, 2018 / 6:20 PM / 3 months ago

BUZZ-Tilray "next in line" for a white knight after Canopy - Citron

** PE-backed Canadian medical marijuana company Tilray’s shares jump ~22 pct amid a rally in cannabis stocks

** "Today is the day that everything has changed in Cannabis," short-seller Citron Research tweets here after Constellation Brands' $4 bln investment in Canopy Growth

** Tilray stock last at $29.59 vs. mid-July IPO price of $17; stock’s jump on Weds. second only to Canopy’s gains

** Citron calls Tilray “best in class” and says stock would be trading at $45 if given same multiple assigned to Canopy

** "Forget about Bitcoin mania, today solidified that Weed in not only real, but also investible despite stretched valuations," Citron, run by Andrew Left, says in a note here

** “It is only time before Tilray reaps the benefits of this mania by either increased shareholder support or more likely a multinational partner or buyout” (Reporting by Savio D’Souza)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below